BNTX: BioNTech SE - ADR Company Profile & Statistics

BioNTech SE - ADR Profile

About

BioNTech SE is a biotechnology company. It develops and commercializes immunotherapies for cancer and other diseases. BioNTech SE is based in Mainz, Germany.

Info & Links

CEO

Headquarters

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

Auditor

Share holders

Employees

BioNTech SE - ADR Statistics

Valuation Measures

Market Capitalization²

22.64B

Enterprise Value

14.26B

Enterprise Value/EBITDA(ttm)

-12.33

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

6.73

Price to Book(mrq)

1.10

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

73.63%

Operating Margin(ttm)

-17.91%

Profit Margin(ttm)

-88.98%

Return on Equity(ttm)

-3.03%

Return on Invested Capital(ttm)

-3.10%

Return on Assets(ttm)

-2.63%

Income Statement

Revenue(ttm)

3.25B

Revenue Per Share(ttm)

Gross Profit(ttm)

2.52B

EBITDA(ttm)³

-1.16B

Net Income Available to Common(ttm)

-1.29B

Diluted EPS(ttm)

-2.63

Share Statistics

Beta (5Y Monthly)

1.49

52-Week Change

-8.97%

S&P 500 52-Week Change

20.12%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

Dividend Yield

0.00%

Float⁴

181.95M

% Held by Insiders

19.20%

% Held by Institutions

15.52%

Balance Sheet

Total Cash(mrq)

16.83B

Total Cash Per Share(mrq)

Total Debt(mrq)

302.54M

Total Debt/Equity(mrq)

1.33%

Current Ratio(mrq)

7.12%

Quick Ratio(mrq)

7.02%

Book Value Per Share(mrq)

89.82

Cash Flow

Operating Cash Flow Per Share(ytd)

0.72

Free Cash Flow(ytd)

45.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.